Rapid and Sustained Improvement in Bone and Cartilage Turnover Markers With the Anti-Interleukin-6 Receptor Inhibitor Tocilizumab Plus Methotrexate in Rheumatoid Arthritis Patients With an Inadequate Response to Methotrexate: Results From a Substudy of the Multicenter Double-Blind, Placebo-Controlled Trial of Tocilizumab in Inadequate Responders to Methotrexate AloneGARNERO, Patrick; THOMPSON, Elizabeth; WOODWORTH, Thasia et al.Arthritis and rheumatism. 2010, Vol 62, Num 1, pp 33-43, issn 0004-3591, 11 p.Article

Effect of interleukin-6 receptor inhibition with tocilizumab in patients with rheumatoid arthritis (OPTION study) : a double-blind, placebo-controlled, randomised trial. CommentaryBONGARTZ, Tim; SMOLEN, Josef S; BEAULIEU, Andre et al.Lancet (British edition). 2008, Vol 371, Num 9617, issn 0140-6736, 961-963, 987-997 [14 p.]Article

Correlation of polymorphic variation in the promoter region of the interleukin-1β gene with secretion of interleukin-1β proteinHALL, Stephanie K; PERREGAUX, David G; GABEL, Christopher A et al.Arthritis and rheumatism. 2004, Vol 50, Num 6, pp 1976-1983, issn 0004-3591, 8 p.Article

Novel combinations of Post-Translational Modification (PTM) neo-epitopes provide tissue-specific biochemical markers—are they the cause or the consequence of the disease?KARSDAL, Morten Asser; HENRIKSEN, Kim; LEEMING, Diana Julie et al.Clinical biochemistry. 2010, Vol 43, Num 10-11, pp 793-804, issn 0009-9120, 12 p.Article

'I'm hurting, I want to kill myself': rheumatoid arthritis flare is more than a high joint count-an international patient perspective on flare where medical help is soughtHEWLETT, Sarah; SANDERSON, Tessa; MAY, James et al.Rheumatology (Oxford. Print). 2012, Vol 51, Num 1, pp 69-76, issn 1462-0324, 8 p.Article

Interleukin-6 Receptor Inhibition With Tocilizumab Reduces Disease Activity in Rheumatoid Arthritis With Inadequate Response to Disease-Modifying Antirheumatic Drugs : The Tocilizumab in Combination With Traditional Disease-Modifying Antirheumatic Drug Therapy StudyGENOVESE, Mark C; MCKAY, James D; NASONOV, Evgeny L et al.Arthritis and rheumatism. 2008, Vol 58, Num 10, pp 2968-2980, issn 0004-3591, 13 p.Article

A randomized controlled trial with an anti-CCL2 (anti-monocyte chemotactic protein 1) monoclonal antibody in patients with rheumatoid arthritisHARINGMAN, Jasper J; GERLAG, Danielle M; LOETSCHER, Pius et al.Arthritis and rheumatism. 2006, Vol 54, Num 8, pp 2387-2392, issn 0004-3591, 6 p.Article

A proposal for developing a large patient population cohort for longterm safety monitoring in rheumatoid arthritisLIPANI, John A; STRAND, Vibeke; JOHNSON, Kent et al.Journal of rheumatology. 2001, Vol 28, Num 5, pp 1170-1173, issn 0315-162XConference Paper

OMERACT 10 Sharp Symposium: Important Findings in Examination of Imaging Methods for Measurement of Joint Damage in Rheumatoid ArthritisSTRAND, Vibeke; KINGSBURY, Sarah R; WELLS, George et al.Journal of rheumatology. 2011, Vol 38, Num 9, pp 2009-2013, issn 0315-162X, 5 p.Article

Assessing single joints in arthritis clinical trialsGILES, Jon T; MEASE, Philip; WAKEFIELD, Richard et al.Journal of rheumatology. 2007, Vol 34, Num 3, pp 641-647, issn 0315-162X, 7 p.Article

Longitudinal performance evaluation and validation of fixed-flexion radiography of the knee for detection of joint space lossNEVITT, Michael C; PETERFY, Charles; GUERMAZI, Ali et al.Arthritis and rheumatism. 2007, Vol 56, Num 5, pp 1512-1520, issn 0004-3591, 9 p.Article

Establishing a Core Domain Set to Measure Rheumatoid Arthritis Flares: Report of the OMERACT 11 RA Flare WorkshopBYKERK, Vivian P; LIE, Elisabeth; MARCH, Lyn et al.Journal of rheumatology. 2014, Vol 41, Num 4, pp 799-809, issn 0315-162X, 11 p.Article

Standardizing assessment and reporting of adverse effects in rheumatology clinical trials. II: The rheumatology common toxicity criteria v.2.0WOODWORTH, Thasia; FURST, Daniel E; JOHNSON, Kent et al.Journal of rheumatology. 2007, Vol 34, Num 6, pp 1401-1414, issn 0315-162X, 14 p.Conference Paper

Outcome variables for osteoarthritis clinical trials: The OMERACT-OARSI set of responder criteriaPHAM, Thao; VAN DER HEIJDE, Désirée; DOUGADOS, Maxime et al.Journal of rheumatology. 2003, Vol 30, Num 7, pp 1648-1654, issn 0315-162X, 7 p.Conference Paper

Standardizing assessment of adverse effects in rheumatology clinical trials. Status of OMERACT Toxicity working group march 2000 : Towards a common understanding of comparative Toxicity /safety profiles for antirheumatic therapiesWOODWORTH, Thasia G; FURST, Daniel E; STRAND, Vibeke et al.Journal of rheumatology. 2001, Vol 28, Num 5, pp 1163-1169, issn 0315-162XConference Paper

Developing a Standardized Definition for Disease Flare in Rheumatoid Arthritis (OMERACT 9 Special Interest Group)BINGHAM, Clifton O; POHL, Christoph; ALTEN, Rieke E et al.Journal of rheumatology. 2009, Vol 36, Num 10, pp 2335-2341, issn 0315-162X, 7 p.Conference Paper

Challenges and progress in adverse event ascertainment and reporting in clinical trialsLASSERE, Marissa N. D; JOHNSON, Kent R; WOODWORTH, Thasia G et al.Journal of rheumatology. 2005, Vol 32, Num 10, pp 2030-2032, issn 0315-162X, 3 p.Conference Paper

MRI assessment of knee osteoarthritis: Knee Osteoarthritis Scoring System (KOSS): inter-observer and intra-observer reproducibility of a compartment-based scoring systemKORNAAT, Peter R; CEULEMANS, Ruth Y. T; KROON, Herman M et al.Skeletal radiology. 2005, Vol 34, Num 2, pp 95-102, issn 0364-2348, 8 p.Article

Developing a Construct to Evaluate Flares in Rheumatoid Arthritis: A Conceptual Report of the OMERACT RA Flare Definition Working GroupALTEN, Rieke; POHL, Christof; WOODWORTH, Thasia G et al.Journal of rheumatology. 2011, Vol 38, Num 8, pp 1745-1750, issn 0315-162X, 6 p.Article

Standardized assessment of adverse events in rheumatology clinical trials : Summary of the OMERACT 7 drug safety module updateLASSERE, Marissa N. D; JOHNSON, Kent R; TUGWELL, Peter S et al.Journal of rheumatology. 2005, Vol 32, Num 10, pp 2037-2041, issn 0315-162X, 5 p.Conference Paper

Assessing Single Joints in Arthritis Clinical TrialsKEEN, Helen I; BINGHAM, Clifton O; MEASE, Philip J et al.Journal of rheumatology. 2009, Vol 36, Num 9, pp 2092-2096, issn 0315-162X, 5 p.Conference Paper

Identifying Preliminary Domains to Detect and Measure Rheumatoid Arthritis Flares: Report of the OMERACT 10 RA Flare WorkshopBINGHAM, Clifton O; ALTEN, Rieke; MAY, James E et al.Journal of rheumatology. 2011, Vol 38, Num 8, pp 1751-1758, issn 0315-162X, 8 p.Article

Prevention of organ allograft rejection by a specific Janus kinase 3 inhibitorCHANGELIAN, Paul S; FLANAGAN, Mark E; MCCURDY, Sandra P et al.Science (Washington, D.C.). 2003, Vol 302, Num 5646, pp 875-878, issn 0036-8075, 4 p.Article